✦ LIBER ✦

The use of psoralen plus Ultra Violet A (UVA) as a new candidate for the treatment of superficial bladder cancer

✍ Scribed by M. Pooya; M. Behzadi; I. Banzola; B. Fischer; G. Sais; F. Heshmati; T. Sulser; M. Provenzano

Book ID: 119344445
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 67 KB
Volume: 8
Category: Article
ISSN: 1572-1000
DOI: 10.1016/j.pdpdt.2011.03.170

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MI5 EXPLORING THE DERIVATION OF UTILITY

MI5 EXPLORING THE DERIVATION OF UTILITY VALUES USING A DISCRETE-CHOICE CONJOINT ANALYSIS METHOD—A COST-UTILITY ANALYSIS OF GEMCITABINE PLUS CISPLATIN FOR THE TREATMENT OF BLADDER CANCER

✍ P Davey; N Rajan 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

PCN19 EXAMINING PREFERENCES AND TIMETRAD

PCN19 EXAMINING PREFERENCES AND TIMETRADE-OFF UTILITY FOR GEMCITABINE PLUS CISPLATIN IN THE TREATMENT OF BLADDER CANCER:A SURVEY USING DISCRETE CHOICE CONJOINT ANALYSIS IN THE UK

✍ A Brown; M Aristides; P FitzGerald; P Davey; S Bhalla; A Kielhorn 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Intravesical chemotherapy for maximum pr

Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection : A combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function

✍ Shiro Hinotsu; Hideyuki Akaza; Yasuo Ohashi; Toshihiko Kotake 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

## BACKGROUND. The effect of intravesical instillation of doxorubicin or epirubicin after transurethral resection (TUR) was estimated from the data of five randomized clinical trials in Japan. The authors provided the estimated hazard function plots with a smoothing technique, to evaluate the prop

Glufosfamide administered using a 1-hour

Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group

✍ E Briasoulis; N Pavlidis; C Terret; J Bauer; W Fiedler; P Schöffski; J-L Raoul; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Commentary on An analysis of the effect

Commentary on An analysis of the effect of statin use on the efficacy of bacillus Calmette-Guerin treatment for transitional cell carcinoma of the bladder: Berglund RK, Savage CJ, Vora KC, Kurta JM, Cronin AM, Division of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY

✍ William A. See 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Commentary on “Identification of 23 new

Commentary on “Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.” Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS–Cancer Research UK GWAS–ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study

✍ Olumi, Aria F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB